well said and with good figures to match
“We are monitoring our corporate costs but given the small size of our corporate team it is our
priority to fulfil our mission - to build a global business of significance for, what we believe, is the
world’s leading oral device to treat obstructive sleep apnea,� said Mr Barschow.
good set of figures given the global climate
Add SOM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
31.0¢ |
Change
-0.010(3.13%) |
Mkt cap ! $66.99M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 32.0¢ | 31.0¢ | $34.11K | 106.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 79696 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.5¢ | 200 | 1 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| SOM (ASX) Chart |